The 21-gene expression assay Oncotype DX Breast Recurrence Scores® is one example of scores that quantify the likelihood of breast cancer recurrence and the potential benefit of chemotherapy in ER+ patients. The gene discussed is ESR1; the disease is breast carcinoma.